Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€68.08
03.01.23
-
03.01.24
-32.29%
28.12.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
03.01.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€526.00
14.12.23
€558.00
14.12.24
0.57%
18.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
14.12.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€568.50
11.10.23
€558.00
11.10.24
-7.48%
14.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
11.10.23 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€156.72
09.12.22
-
09.12.23
-11.18%
10.12.23

Joe130978 
09.12.22 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.86
04.11.23
€89.00
04.12.23
-4.82%
05.12.23

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
04.11.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€370.05
04.11.22
€610.00
04.11.23
44.17%
05.11.23

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
gerihouse 
04.11.22 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€67.38
13.10.22
€46.00
13.10.23
9.44%
14.10.23

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
13.10.22 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€533.50
19.09.23
€558.00
19.09.24
6.56%
11.10.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
19.09.23 50%
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€219.65
06.10.22
-
06.10.23
-39.65%
06.10.23

Joe130978 
06.10.22 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€422.40
27.06.23
€800.00
31.01.29
20.50%
01.10.23

Could be very worthwhile Investment >20% year
BiotechBee 
27.06.23 80%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
19.09.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€228.00
20.09.22
€270.00
20.09.23
11.84%
21.09.23

maria3 
20.09.22 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€103.36
19.09.22
€130.00
19.09.23
-8.59%
20.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
gerihouse 
19.09.22 70%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€247.05
26.12.22
€255.00
26.12.23
-0.10%
19.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
26.12.22 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€555.50
15.09.23
€558.00
15.09.24
-3.96%
19.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
15.09.23 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.59
16.09.22
-
16.09.23
9.92%
16.09.23

Joe130978 
16.09.22 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€309.00
15.09.22
€550.00
15.09.23
74.76%
16.09.23

Ankica 
15.09.22 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€502.50
17.08.23
€510.00
17.08.24
10.75%
13.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
17.08.23 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€69.65
22.12.22
-
22.12.23
-0.67%
24.08.23

Finanzoo 
22.12.22 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.74
22.08.22
€80.00
22.08.23
8.80%
23.08.23

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
bullbear 
22.08.22 90%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.60
24.07.23
€155.00
24.07.24
3.47%
16.08.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
24.07.23 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€176.92
03.08.22
€190.00
03.08.23
-6.34%
03.08.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
tbackenh 
03.08.22 80%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
20.07.22 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€175.60
13.07.22
€168.00
13.07.23
-19.13%
13.07.23

francisco20 
13.07.22 50%
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€235.25
13.07.22
€239.00
13.07.23
-1.59%
13.07.23

francisco20 
13.07.22 50%